A review on the porous adsorbents in drug delivery systems

Pharmaceutical Sciences

Volumn 18, Issue 2, 2012, Pages 103-118

  Adibkia, K ^a,b   Barzegar Jalali, Mohammad ^b,c   Javadzadeh, Y ^b,c   Bayrami, R ^b   Mohammadi, G ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adsorption; Drug loading; Porosity; Porous adsorbants; Review

Indexed keywords

ADSORBENT; DRUG CARRIER; MCM 41; SBA 15; UNCLASSIFIED DRUG;

CERAMICS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG RELEASE; DRUG SOLUBILITY; REVIEW;

EID: 84872662414     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Lapus R.M. Activated charcoal for pediatric poisonings: the universal antidote? Journal of Current Opinion in Pediatrics, 2007, 19: 216-222.
2. Atkins P.W., Physical chemistry, Oxford university press, Oxford, 1988, 770-783.
3. Ahuja G., Pathak K. Porous carriers for controlled/modulated drug delivery, Indian journal of Pharmaceutical Sciences, 2009, 71: 559-607.
4. Ukmar T., Planinsek O. Ordered mesoporous silicates as matrices for controlled release of drugs, Acta pharmaceutica, 2010, 60: 373-385.
5. Wang Q., Zhang J., Wang A. Preparation and characterization of a novel pH-sensitive chitosan-g-poly (acrylic acid)/attapulgite/sodium alginate composite hydrogel bead for controlled release of diclofenac sodium, Carbohydrate Polymers, 2009, 78: 731-737.
6. Tang B., Cheng G., Gu J.C., Xu C.H. Drug delivery systems: preparation techniques and dosage form, Drug Discovery Today, 2008, 13:606-612.and dosage forms
7. Zhou Y. Nanotubes: A New carrier for drug delivery systems, The Open Nanoscience Journal, 2008, 2: 1-5 1.
8. Vadia N., Rajput S. Mesoporous material, MCM41: a newdrug carrier, Asian Journal of Pharmaceutical and Clinical Research, 2011, 4: 44-53.
9. Li Z.Z., Wen L.X., Shao L., Chen J.F. Fabrication of porous hollow silica nanoparticles and their applications in drug release control, Journal of Controlled Release, 2004, 98: 245-254
10. Coelho J.F., Ferreira P. C., Alves P., Cordeiro R., Fonseca A. C., Góis J. R., Gil M. H. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments, EPMA Journal, 2010, 1: 164-209.
11. Kairemo K., Erba P., Bergström K., Pauwels E.K.J. Nanoparticles in cancer, Current Radiopharmaceuticals, 2008, 1:30-36.
12. Yiu H. H. P., Niu H. j., Biermans E., Tendeloo G.V., Rosseinsky M. J. Designed multifunctional nanocomposites for biomedical applications, Advanced Functional Materials, 2010, 20: 1-11.
13. Huang S. L. liposom in ultrasonicdrug and gene delivery, Advanced Drug Delivery Reviews, 2008, 60: 1167-1176.
14. Antovska P., Cvetkovska M., Goracinova K. Preparation and characterization of sol-gel processed spray dried silica xerogel microparticles as carriers of heparin sodium, Bulletin of the Chemists and Technologists of Macedonia, 2006, 25: 121-126.
15. Cauda V., Fiorilli S., Onida B., Vernè E., Vitale Brovarone C., Viterbo D., Croce G., Milanesio M., Garrone E. SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery, Journal of Material sciences, 2008, 19: 3303-3310.
16. Vallet-Regí M., Balas F. Silica Materials for medical applications,The Open Biomedical Engineering Journal, 2008, 2:1-9.
17. Nakai Y., Yamamoto K., Izumikawa S. Interaction of medicinals and porous powder. III. : effects of pore diameter of porous glass powder on crystalline properties, journal of Chemical and Pharmaceutical Bulletin, 1989, 37: 435-438.
18. Chen H.T., Trewyn B. G., Wiench J. W., Pruski M., Lin V.S. Y. Urea and thiourea-functionalized mesoporous silica nanoparticle catalysts with enhanced catalytic activity for diels-alder reaction, Topics in Catalysis, 2010, 53: 187-191.
19. Wang C., He C., Tong Z., Liu X., Ren B., Zeng F. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery, International Journal of Pharmaceutical Sciences, 2006, 308: 160-167.
20. Heikkilä T., Riikonen J., Mäkilä E., Salonen J., Hirvonen J., Laaksonen T., Peltonen L., Santos H., Lehto V.P. Feasibility of silicon-based mesoporous materials for oral drug delivery applications, Dosis, 2008, 24: 129-149.
21. Buentello F. S., Persad D. L., Court E. B., Martin D.K., Daar A. S., Singer P. A. Nanotechnology and the developing world, PLoS Medicine, 2005, 2: 1-4.
22. Ayon A. A., Cantu1 M., Chava K., Agrawal C.M., Feldman M. D., Johnson D., Patel D., Marton D., Shi E. Drug loading of nanoporous TiO2 films, Journal of Biomedical Materials, 2006, 1: 11-15.
23. Heredia-Cervera B. E., González-Azcorra S. A., Rodríguez-Gattorno G., López T., Ortiz-Islas E., Oskam G. Controlled release of phenytoin from nanostructured TiO2 reservoirs, Science of Advanced Materials, 2009,1: 63-68.
24. Sander C., Holm P. Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation, Journal of Pharmaceutical Sciences and Technology, 2009, 10: 1388-1395.
25. Shi X., Li J. P., Tanga Y., Yangb Q. pH-Sensitive mesoporous zirconium diphosphonates for controllable colontargeted Delivery, Journal of Materials Chemistry, 2010, 20: 6495-6504.
26. Reddy B.P. N., Gupta B., Gacche R. N. An Arsenal for 21st Century Noxious Diseases: Carbon Nanomaterials, International Journal of Nanotechnology and Applications, 2009, 3: 61-76.
27. Sher P., Ingavle G., Ponrathnam S., Pawar A. P. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents, International Journal of Pharmaceutics, 2007, 331: 72-83.
28. Baskar G.V., Narayanan N., Gaikwad R., Abdul S. Formulation and evaluation of gastro-retentive floating multi-particulate System of metoprolol tartarate, Tropical Journal of Pharmaceutical Research, 2010, 9: 181-186.
29. Salonen J., Kaukonen A. M., Hirvonen J., Lehto V.P. Mesoporous silicon in drug delivery applications, Journal of Pharmaceutical Sciences, 2007, 10-1002:1-22.
30. Sheth N. S. Formulation and evalution of solid dispersion of olanzapine, International Journal of Pharmaceutical Sciences and Research, 2011, 2: 691-697.
31. Byrne R.S., Deasy P.B. Use of commercial porous ceramic particles for sustained drug delivery, International Journal of Pharmaceutics, 2002, 246: 61-73.
32. Germain J., Frechetab J. M. J., Svec F. Hypercrosslinked polyanilines with nanoporous structure and high surface area: potential adsorbents for hydrogen storage, Journal of Materials Chemistry, 2007, 17: 4989- 4997.
33. Tiseanu C., Kumke M.U., Parvulescu V.I., Kot A.S.R., Gagea B.C., Martens J.A. Time-resolved photoluminescence of terbium-doped microporous- mesoporous Zeotile-1 materials, Journal of Photochemistry and Photobiology A: Chemistry, 2007, 187: 299-304.
34. Song S. W., Hidajat K., Kawi S., Functionalized SBA- 15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions, Langmuir, 2005, 21: 9568-9575.
35. Han Y. J., Watson J. T., Stucky G.D., Butler A. Catalytic activity of mesoporous silicate-immobilized chloroperoxidase, Journal of Molecular Catalysis B: Enzymatic, 2002, 17: 1-8.
36. Jayarajan M., Arunachalam R., Annaduria G. Agricultural wastes of jack fruit peel nano-porous adsorbent for removal of rhodamin dye, Asian Journal of Applied Sciences, 2011, 4: 263-270.
37. Bouvy C., Marine W., Sporken R., Su B. L. Photoluminescent properties of polyoxyethylene alkyl ether-type neutral surfactant templated mesoporous materials CMI-1: The absence of the 1.9 eV PL band, Chemical Physics Letters, 2006, 420: 225-229.
38. Guo H., Qian H., Sun S., Sun D., Yin H., Cai X., Liu Z., Wu J., Jiang T., Liu X. Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye, Chemistry Central Journal, 2011, 5: 1-10.
39. Kupplera R. J., Timmonsb D. J., Fanga Q.R., Li J.R., Makala T. A., Younga M.D., Yuana D., Zhaoa D., Zhuanga W., Zhoua H.C. Potential applications of metal-organic frameworks, Coordination Chemistry Reviews, 2009,253: 3042-3066.
40. McCusker L. B., Liebau F., Engelhardt G., Nomenclature of structural and compositional characteristics of ordered microporous and mesoporous materials with inorganic hosts, Pure and Applied Chemistry, 2001, 73: 381-394.
41. Weitkamp J., Hunger M., Rymsa U. Base catalysis on microporous and mesoporous materials: recent progress and perspectives, Microporous and Mesoporous Materials, 2001, 48: 255-270.
42. Trewyn B. G., Slowing I. I., Giri S., Chen H.T., Lin V. S. Y. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release, Accounts of Chemicasl Research, 2007, 40: 846-853.
43. Prins R., Pirngruber G., Weber T. Metal phosphides and Zeolite-like mesoporous materials as catalysts, Journal of Chimia, 2001, 55 : 791-795.
44. Ishizaki K., Komarneni S., Nanko M. In Porous materials: process technology and Applications, Chapman & Hall, kluwer academic, netherland, 1998, 1-10.
45. Logar N. Z., Kaucic V. Nanoporous materials: from catalysis and hydrogen storage to wastewater treatment, Acta Chimica Slovencia, 2006, 53, 117-135
46. Nunes C. D., Vaz P. D., Branda P., Rocha J., Ferreira P., Bion N., Calhorda M. J. Synthesis and characterisation of hybrid mesoporous materials with the 1, 4-diazobutadiene ligand, Microporous and Mesoporous Materials, 2006, 95: 104-111.
47. Morell J., Gungerich M., Wolter G., Jiao J., Hunger M., Klar P. J., Froba M. Synthesis and characterization of highly ordered bifunctional aromatic periodic mesoporous organosilicas with different pore sizes, Journal of Materials Chemistry, 2006, 16: 2809-2818.
48. Kawanabe K., Okada Y., Matsusue Y., Iida H., Nakamura T. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic, Journal of Bone and Joint Surgery, 1998, 80: 1-4.
49. Galo J. A., Soler-Illia A., Sanchez C., Lebeau B., Patarin J. Chemical strategies to design textured materials: from microporous and mesoporous oxides to nanonetworks and hierarchical Structures, Chemical Reviews, 2002, 102: 4093-4138.
50. Reddy V. R., Currao A., Calzaferri G. Zeolite A and zeolite L monolayers modified with AgCl as photocatalyst for water oxidation to O2, Journal of Materials Chemistry, 2007, 17: 3603-3609.
51. Zhang H., Kim Y., Dutta P. K. Controlled release of paraquat from surface-modified zeolite Y, Microporous and Mesoporous Materials, 2006, 88: 312-318.
52. Xiao B., Yuan Q. Nanoporous metal organic framework materials for hydrogen storage, Journal of Particuology, 2009, 7: 129-140
53. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J. F., Heurtaux D., Clayette P., Kreuz C., Chang J.S., Hwang Y. K., Marsaud V., Bories P. N., Cynober L., S.Gil, G. Ferey, P.Couvreur, R. Gref Porous metal -organic framework nanoscale carriers as a potential platform for drug delivery and imaging, Nature Materials, 2010, 9: 172-178.
54. Huxford R. C., Rocca J. D., Lin W. Metal-organic frameworks as potential drug carriers, Current Opinion in Chemical Biology, 2010, 14: 262-268.
55. Keskin S., Kizilel S. Biomedical applications of metalorganic frameworks, Industrial & Engineering Chemistry Research, 2011, 50: 1799-1812.
56. Fang Q.R., Makal T. A., Young M. D., Zhou H. C. Recent advances in the study of mesoporous metal-organic frameworks, Comments on Inorganic Chemistry, 2010, 31: 165-195.
57. Lin H.P., Mou C.Y., Liu S.B., Tang C.Y., Lin C.Y. Post-synthesis treatment of acid-made mesoporous silica materials by ammonia hydrothermal process, Microporous and Mesoporous Materials, 2001, 44:129-137.
58. Taylor-Pashow K. M. L., Rocca J. D., Xie Z., Tran S., Lin W. Post-synthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery, Journal of the American Chemical Society, 2009, 131: 14261-14263.
59. Farha O. K., Hupp J.T. Rational Design, Synthesis, Purification, and Activation of Metal-Organic Framework Materials, Accounts of Chemical Research, 2010, 43: 1166-1175.
60. Choi M., Srivastava R., Ryoo R. Organosilane surfactant-directed synthesis of mesoporous aluminophosphates constructed with crystalline microporous frameworks, Journal of Chemical Commmunications, 2006, 4380-4382.
61. Beck J.S., Vertuli J.C., Roth W.J., Leonowicz M.E., Kresge C.T., Schmitt K.D., Chu C., Olson D.H., Sheppard E.W., McCullen S.B., Higgins J.B., Schlenker J.L. A new family of mesoporous molecular sieves prepared with liquid crystal templates, Journal of the American Chemical Society, 1992, 114: 10834-10843.
62. Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism, Nature, 1992, 359: 710-712.
63. Hassani S. S., Salehirad F., Aghabozorg H. R., Sobat Z. Synthesis and morphology of nanosized zeolite L, Crystal Reserch and Technology, 2010, 45: 183-187.
64. Lee C. H., Lo L. W., Mou C.Y., Yang C. S. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug, Advanced Functional Materials, 2008, 18: 3283-3292.
65. Samart C., Iriwech W. S., Sookman C. Nano porous silica and its application in drug delivery, Journal of National Sciences, 2008, 7: 191-196.
66. Angelis F. D., Pujia A., Falcone C., Iaccino E., Palmieri C., Liberale C., Mecarini F., Candeloro P., Luberto L., Laurentiis A., Das G., Scala G., Fabrizio E. D. water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context, Journal of Nanoscale, 2010, 2: 2230-2236.
67. Xue J.M., Tan C. H., Lukito D. Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. Journal of Biomedical Materials Research: Part B, 2006, 78: 417-422.
68. Sousa A., Sousa E.M.B. Ordered mesoporous silica carrier system applied in nanobiothecnology, Brazilian Archives of Biology and Technology, 2005, 48: 243-250.
69. Cho Y., Shi R., Borgens R.B., Ivanisevic A. The functionalized mesoporous silica nanoparticles (MSNS) based drug delivery system to rescue acrolein-mediated cell death, Nanomedicine, 2008, 3: 507-519.
70. Young P., Yong K., Kyong Y., Jaie C., Haing C., Su C.C. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery, International Journal of Pharmaceutical Sciences, 2008, 359: 280-287.
71. Sousa A., Souza K.C., Sousa E.M.B. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery, Acta Biomaterialia, 2008, 4: 671-679.
72. Samart C., Sookman C. Effect of silica sources in nanoporous silica synthesis on releasing behavior of indigo carmine, Songklanakarin Journal of Sciences and Technology, 2009, 31: 511-515.
73. Janicke M. T., Landry C. C., Christiansen S. C., Birtalan S., Stucky G. D., Chmelka B. F. Low Silica MCM-41 Composites and mesoporous solids, Journal of Chemistry Materials, 1999, 11: 1342-1351.
74. Ambrogia V., Periolia L., Marmottinib F., Giovagnolia S., Espositoa M., Rossi C. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate, Eurpean Journal of Pharmaceutical Sciences, 2007, 32: 216-222.
75. Kong D., Yang P., Wang Z., Chai P., Huang S., Lian H., Lin J. Mesoporous Silica Coated CeF3:Tb3+ Particles for Drug Release, Journal of Nanomaterials, 2008, 1: 1-7.
76. Ambrogi V., Perioli L., Marmottini F., Moretti M., Lollini E., Rossi C., Chlorhexidine MCM-41 mucoadhesive tablets for topical use, Journal of Pharmaceutical Innovation, 2009, 4: 156-164.
77. Barba I.I., Martinez Á., Doadrio A.L., Pariente J.P., Vallet-Regí M. Release evaluation of drugs from ordered three-dimensional silica structures, European Journal of Pharmaceutial Sciences, 2005, 26: 365-373.
78. Speybroeck M.V., Barillaro V., Thi T.D., Mellaerts R., Martens J., Humbeeck J. V., Vermant J., Annaert P., Mooter G. V., Augustijns P. Ordered mesoporous silica materials SBA-15: A broad spectrum formulation platform for poorly soluble drugs, Journal of Pharmaceutical sciences, 2008, 98: 2648-2658
79. Kruk M., Jaroniec M. Characterization of the porous structure of SBA-15, Journal of Chemistry materials, 2000, 12: 1961-1968.
80. Naik B., Ghosh N. N. A Review on chemical methodologies for preparation of mesoporous silica and alumina based materials, Recent Patents on Nanotechnology, 2009, 3: 213-224.
81. Lievens K. J. F., Meynen V., Cool P., Vansant E. F., Baron G.V., Denayer J. F. M. The release properties of the mesoporous materials SBA-15 and PHTS for their Use in the controlled release of ibuprofen and vancomycin, journal of Diffusion Fundamentals, 2005, 2: 99-99.
82. Blumen S. R., Cheng K., Nino M. E. R., Douglas J. T., Taatjes D. J., Weiss D. J., Landry C. C., Mossman B. T. Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells, American journal of Resppiratory Cell Molecular Biology, 2007, 36: 333-342.
83. Lin Y. S., Tsai C. P., Huang H. Y., Kuo C. T., Hung Y., Huang D. M., Chen Y. C., Mou C. Y.Well-ordered mesoporous silica nanoparticles as cell markers, Journal of Chemistry Materials, 2005, 17: 4570-4573.
84. Vallet-Regí M., Balasa F., Colillaa M., Manzano M. Bioceramics and pharmaceuticals: A remarkable synergy, Solid State Sciences, 2007, 9: 768-776.
85. Wang S. Ordered mesoporous materials for drug delivery, Microporous and Mesoporous Materials, 2009, 117: 1-9.
86. Pasquaa L., Testaa F., Aielloa R., Cundaria S., Nagy J.B. Preparation of bifuctional hybrid mesoporous silica potentially for drug targeting, Microporous and Mesoporous Materials, 2007, 103: 166-173.
87. Mellaerts R., Aerts C.A., Humbeeck J., Augustijns P., Mooter G., Martens J. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials, Journal of Chemical Communication, 2007, 1375-1377.
88. Fagundesa L.B., Sousab T.G.F., Sousac A., Silvac V.V., Sousa E.M.B. SBA-15-collagen hybrid material for drug delivery applications. Journal of Non-Crystalline Solids, 2006, 352: 3496-3501.
89. Lin C.X., Qiao S.Z., Yu C.Z., Suryadi I., Lu G.Q. Periodic mesoporous silica and organosilica with controlled morphologies as carriers for drug release, Microporous and Mesoporous Materials, 2009, 117: 213-219.
90. Nguyen T., Wook L.J., Shim W.G., Hee M. Synthesis of functionalized SBA-15 with ordered large pore size and itsadsorption properties, Microporous and Mesoporous Materials, 2008, 110: 560-569.
91. Heikkiläa T., Salonena J., Tuuraa J., Hamdyb M.S., Mulb G., Kumarc N., Salmic T., DYu M., Laitinend L., Kaukonend A.M., Hirvonene J., Lehto V. P. Mesoporous silica material TUD-1 as a drug delivery system, International Journal of Pharmaceuticals, 2007, 331: 133-138.
92. Zhua Y., Chena J. S. H., Shena W., Dong X. A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property, Microporous and Mesoporous Materials, 2005, 84: 218-222.
93. Shenmin Z., Di Z., Yang N. Hydrophobic polymers modification of mesoporous silica with large pore size for drug release, Journal of Nanoparticle research, 2009, 11: 561-568
94. Kim J., Lee J. E., Lee J., Yu J. H., Kim B. C., An K., Hwang Y., Shin C.H., Park J.G., Kim J., Hyeon T. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals, Journal of the American Chemical Society, 2006, 128: 688-689.
95. Vallet-Regí M., Balas F., Colilla M., Manzano M., Drug confinement and delivery in ceramic implants, Journal of Drug Metabolism Letters, 2007, 1: 37-40.
96. Salata O.V. Applications of nanoparticles in biology and medicine, Journal of Nanobiotechnology, 2004, 2: 1-6.
97. Colombo P., Vakifahmetoglu C., Costacurta S., Fabrication of ceramic components with hierarchical porosity, Journal of Material Sciences, 2010, 9: 1-31.
98. Prawingwong P., Chaiya C., Reubroycharoen P., Samart C. Utilization of rice husk ash silica in controlled releasing application, Journal of Metals, Materials and Minerals, 2009, 19: 61-65.
99. Meynen V., Cool P., Vansant E.F. Verified syntheses of mesoporous materials, Microporous and Mesoporous Materials, 2009, 125: 170-223.
100. Gbureck U., Vorndran E., Barralet J.E. Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions, Journal of Acta Biology, 2008, 4: 1480-1486.
101. Sarmiento A., Montes A.M., Hotza D., Novaes de Oliveira A.P., Escobar J.A. Design and fabrication of cellular glass ceramic structures for filtering combustion gases of diesel engines, Journal of Revista latinoamericana de Metalurgiay Materiales, 2009, 1: 353-363.
102. Mazali I.O., Alves O.L. Fabrication of a new porous Glass-Ceramic monolith using vanadium(III) calcium phosphate glass as precursor, Journal of Brazilian Chemical Society, 2004, 15: 464-467.
103. Sooksaens P., Suttiruengwong S., Oniem K., Ngamlamiad K., Atireklapwarodom J., Fabrication of porous bioactive Glass-Ceramics via decomposition of natural fibres, Journal of Metals, Materials and Mineral, 2008, 18: 85-91.
104. Colilla M., Manzano M., Vallet-Regí M. Recent advances in ceramic implants as drug delivery systems for biomedical applications, International Journal of Nanomedicine, 2008, 3: 403-414.
105. Cosijns A., Vervaet C., Luyten J., Mullens S., Siepmann F., Hoorebeke L. V., Masschaele B., Cnudde V., Remon J.P. Porous hydroxyapatite tablets as carriers for low-dosed drugs, European Journal of Pharmaceutics and Biopharmaceutics, 2007, 67: 498-506.
106. Im S. H., Park O. O. Fabrication of Polymeric Hollow Spheres Having Macropores by a Quenching and Sublimation Process, Journal of Macromolecular Research, 2003, 11: 518-522.
107. Zhao X. S. Novel porous materials for emerging applications, Journal of Materials Chemistry, 2006, 16: 623-625.
108. Xu H.T., Wang X. S., Tao L.M. Wu S. X. Fabrication and sustained release properties of porous hollow silica nanoparticles, Science China Chemistry, 2010, 53: 556-561.
109. Otsuka M., Tokumitsu K., Matsuda Y. Solid dosage form preparations from oily medicines and their drug release: effect of degree of surface modification of silica gel on the drug release from phytonadione-loaded silica gel, Journal of Controlled Release, 2000, 67:369-384.
110. Gani R., Jiméz-González C., ten Kate A., CraftsP.A., Jones M., Powell L., Atherton J.H. Cordiner J.L., A modern approach to solvent selection, Journal of Chemical Engineering, 2006, 113: 30-43.
111. Ali S.H. Measurement and prediction of pyrene solubility in pure, binary, ternary and quaternary solvent systems, Journal of Fluid Phase Equilibria, 2008, 264: 29-44.
112. Hancock B.C., York P. Rowe R.C., The use of solubility parameters in pharmaceutical dosage form design, International Journal of Pharmaceutics, 1997, 148: 1-21.
113. Florence A.T., Attwood D., Phisicochemical principle of pharmacy, the Macmillan press LTD, London, 1998, 212.
114. Limnell T., Riikonen J., Salonen J., Kaukonen A.M., Laitinen L., Hirvonen J., Lehto V.P. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles, International Journal of Pharmaceutics, 2007, 343: 141-147.
115. Kaukonen A.M., Laitinen L., Salonen J., Tuura J., Heikkilä T., Limnell T., Hirvonen J., Lehto, V. P. Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles, European Journal of Pharmaceutics and Biopharmaceutics 2007, 66: 348-356.
116. Bahl D., Bogner R., Amorphization of indomethacin by co-grinding with neusilin US2: amorphization kinetics, physical stability and mechanism, Journal of Pharmaceutical Research, 2006, 23: 2317-2325.
117. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Björkqvist M., Heikkilä T., Vähä-Heikkilä K., Hirvonen J., Lehto, V. P. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs, Journal of Controlled Release 2005, 108: 362-374.
118. Guo P., Martin C. R., Zhao Y., Ge J., Zare R. N. General method for producing organic nanoparticles using nanoporous membranes, Journal of Nanotechnology Letters, 2010, 10: 2202-2206.
119. Kumar D.S., Banji D., Madhavi B. B., Bodanapu V., Dondapati S., Sri A. P.l Nanostructured porous silicon - a novel biomaterial for drug delivery, International Journal of Pharmacy and Pharmaceutical Sciences, 2009, 1: 1-9.
120. Behnoush B., Bazmi E., Taghaddosinejad F. Carbamazepine poisoning and effect of mulriple-dose activated charcoal, Journal of Acta Medica Iranica, 2009, 47: 1-14.
121. Martz P. Rethinking routine use of activated charcoal, Journal of Toxicology Today, 2008, 10: 1-4.
122. Larue C., Gueraud V., Rivat C. Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma, Journal of Clinical and Experimental Immunology, 1985, 62: 217-224.
123. Malik D.J., C.Webb, R.G. Holdich, J.J. Ramsden, G.L. Warwick, I. Roche, D.J. Williams, A.W. Trochimczuk, J.A. Dale, N.A. Hoenich synthesis and characterization of size-selective nanoporous polymeric adsorbent for blood purification, Journal of Separation and Purification Technology, 2009, 66: 578-585.
124. Asada T., Oikawa K., Kawata K., Ishihara S., Iyobe T., Yamada A. Study of removal effect of bisphenol A and ß-estradiol by porous carbon, Journal of Health Science, 2004, 50: 588-593.